Literature DB >> 4394125

Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.

M Nishida, T Matsubara, T Murakawa, Y Mine, Y Yokota.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4394125     DOI: 10.7164/antibiotics.23.137

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  17 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

Authors:  E S Rattie; L J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  β-Lactamase Resistant Cephalosporins with Particular Reference to Cefuroxime.

Authors:  M H Richmond
Journal:  Proc R Soc Med       Date:  1977

4.  Rate of binding of antibiotics to canine serum protein.

Authors:  N Waterman; L Scharfenberger; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

5.  Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.

Authors:  T Nishi; K Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals.

Authors:  M Komiya; Y Kikuchi; A Tachibana; K Yano
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

7.  Semiautomated turbidimetric microbiological assay for determination of cefazolin.

Authors:  D Pitkin; P Actor; W Holl; A Post; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

8.  Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.

Authors:  M F Rein; F B Westervelt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

9.  Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.

Authors:  M H Richmond; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

10.  Laboratory evaluation of FR10024 a new cephalosporin derivative.

Authors:  M Nishida; T Murakawa; T Kamimura; N Okada; S Fukada
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.